静脉旁路联合胸廓出口减压治疗上肢中心静脉闭塞
本研究回顾性分析14例症状性锁骨下静脉闭塞患者,采用静脉旁路联合胸廓出口减压治疗,平均随访357天,一期辅助通畅率71.4%,二期通畅率85.7%,93%患者无症状复发。
要点
- 静脉旁路联合胸廓出口减压可缓解约90%症状性上肢中心静脉闭塞患者的症状。
- 股静脉作为旁路导管在队列中一期辅助通畅率达100%。
- 并发症限于围手术期,包括移植物血栓形成、伤口裂开等。
核心结论
- 静脉旁路联合胸廓出口减压对症状性上肢中心静脉闭塞患者症状缓解率约90%,并发症局限于围手术期。
研究设计与样本
- 前瞻性收集数据库查询2012年7月至2017年12月间因症状性静脉胸廓出口综合征合并同侧动静脉通路接受静脉旁路治疗的连续患者。
- 共纳入14例患者(8例男性,平均年龄42岁),均接受开放胸廓出口减压(第一肋切除n=11或锁骨切除n=4)。
主要发现
- 平均随访357(±303)天,全队列一期辅助通畅率71.4%,二期通畅率85.7%。
- 股静脉导管亚组一期辅助通畅率为100%。
- 末次随访时14例存活患者中13例(93%)无症状。
- 2例早期移植物血栓形成,分别经颈静脉翻转和股静脉旁路修正。
- 所有患者术后即刻症状缓解,并发症包括2例移植物血栓形成、2例伤口裂开、2例手术部位血肿、非ST段抬高型心肌梗死、静脉 harvest 部位感染、聚四氟乙烯移植物感染及膈神经损伤。
临床怎么用
- 对于症状性上肢中心静脉闭塞且不适合腔内治疗的患者,可考虑静脉旁路联合胸廓出口减压。
- 股静脉作为旁路导管可能提供更优的一期辅助通畅率。
局限性
- 样本量小(14例),随访时间有限(平均357天),且为单中心回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Upper extremity central venous stenosis results from a variety of environmental and anatomic conditions, including venous thoracic outlet syndrome, the presence of device leads or catheters, and the turbulence created by the presence of arteriovenous fistulas or grafts. In cases of total occlusion, especially at the bony costoclavicular junction, options for endovascular treatment and open venous reconstruction are limited and bypass grafting may be needed. We describe our experience with venous bypass combined with thoracic outlet decompression in a cohort of symptomatic patients with subclavian vein occlusion. METHODS: A prospectively collected database of patients was queried for patients treated for central venous obstructive disease with venous bypass in the setting of both symptomatic venous thoracic outlet syndrome and ipsilateral arteriovenous access from July 2012 to December 2017. All but one patient presented with arm swelling and had either failed to respond to or were unsuitable for endovenous therapy. One patient desired elective removal of a venous stent because of pain and anxiety. Operative procedures were performed at the discretion of the operating surgeon. RESULTS: Fourteen patients (eight men; average age, 42 years) underwent open thoracic outlet decompression with first rib resection (n = 11) or claviculectomy (n = 4). Indication for treatment was dialysis-associated venous outlet obstruction in five, effort thrombosis (Paget-Schroetter syndrome) in seven, presence of a venous implantable cardioverter-defibrillator lead in one, and patent but painful venous stent in situ with significant anxiety. Nine patients required first interspace sternotomy for exposure of the proximal subclavian vein. One patient with acute Paget-Schroetter syndrome had been treated with preoperative thrombolysis without resolution; all others were chronically occluded. Bypass conduit was jugular vein in one, bovine carotid artery graft in two, paneled great saphenous vein in two, femoral vein in eight, and polytetrafluoroethylene in one. Mean operative time was 187 (±45) minutes, with mean estimated blood loss of 379 (±209) mL. There were two early graft thromboses that were revised with jugular venous turndown and femoral vein bypass, respectively. All patients experienced immediate symptom relief. Morbidity included two graft thromboses, two instances of wound dehiscence, two operative site hematomas, non-ST elevation myocardial infarction, vein harvest site infection, polytetrafluoroethylene graft infection, and phrenic nerve injury. At a mean follow-up of 357 (±303) days, primary assisted patency and secondary patency for the entire cohort were 71.4% and 85.7%, respectively, with 100% primary assisted patency among those with femoral vein conduit. At last follow-up, 13 of the 14 living patients (93%) remained symptom free. CONCLUSIONS: In our experience, venous bypass combined with thoracic outlet decompression achieves symptomatic relief in approximately 90% of patients with symptomatic upper extremity central venous occlusion, with morbidity limited to the perioperative period.
引用
- Edwards JB, Brooks JD, Wooster MD, et al. Outcomes of venous bypass combined with thoracic outlet decompression for treatment of upper extremity central venous occlusion. J Vasc Surg Venous Lymphat Disord. 2019. PMID: 31176658. doi:10.1016/j.jvsv.2019.03.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。